BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee CC, Wu CW, Lo SS, Chen JH, Li AF, Hsieh MC, Shen KH, Lui WY. Survival predictors in patients with node-negative gastric carcinoma. J Gastroenterol Hepatol. 2007;22:1014-1018. [PMID: 17608847 DOI: 10.1111/j.1440-1746.2006.04488.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Sekiguchi M, Sekine S, Oda I, Nonaka S, Suzuki H, Yoshinaga S, Taniguchi H, Tsuda H, Kushima R, Saito Y. Risk factors for lymphatic and venous involvement in endoscopically resected gastric cancer. J Gastroenterol 2013;48:706-12. [PMID: 23090003 DOI: 10.1007/s00535-012-0696-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
2 Baiocchi GL, Molfino S, Baronchelli C, Giacopuzzi S, Marrelli D, Morgagni P, Bencivenga M, Saragoni L, Vindigni C, Portolani N, Botticini M, De Manzoni G. Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series. World J Gastroenterol 2017;23:8000-7. [PMID: 29259375 DOI: 10.3748/wjg.v23.i45.8000] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xu M, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J. Does tumor size improve the accuracy of prognostic predictions in node-negative gastric cancer (pT1-4aN0M0 stage)? PLoS One 2014;9:e101061. [PMID: 25003849 DOI: 10.1371/journal.pone.0101061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liu X, Cai H, Shi Y, Wang Y. Prognostic factors in patients with node-negative gastric cancer: a single center experience from China. J Gastrointest Surg. 2012;16:1123-1127. [PMID: 22488657 DOI: 10.1007/s11605-012-1881-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
5 Das S, Skobe M. Lymphatic vessel activation in cancer. Ann N Y Acad Sci 2008;1131:235-41. [PMID: 18519976 DOI: 10.1196/annals.1413.021] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
6 Jiao XG, Deng JY, Zhang RP, Wu LL, Wang L, Liu HG, Hao XS, Liang H. Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. World J Gastroenterol. 2014;20:3640-3648. [PMID: 24707149 DOI: 10.3748/wjg.v20.i13.3640] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
7 Kang Y, Wang F, Zu H, Yang Z, Xue Y. A New Subclassification of pT4 Gastric Cancers According to the Width of Serosal Invasion. PLoS One 2013;8:e68042. [PMID: 23826361 DOI: 10.1371/journal.pone.0068042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Du CY, Chen JG, Zhou Y, Zhao GF, Fu H, Zhou XK, Shi YQ. Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer. World J Gastroenterol. 2012;18:3610-3616. [PMID: 22826628 DOI: 10.3748/wjg.v18.i27.3610] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
9 Ichikawa D, Kubota T, Kikuchi S, Fujiwara H, Konishi H, Tsujiura M, Ikoma H, Nakanishi M, Okamoto K, Sakakura C, Ochiai T, Kokuba Y, Otsuji E. Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer. J Surg Oncol. 2009;100:111-114. [PMID: 19475584 DOI: 10.1002/jso.21311] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
10 Imamura T, Komatsu S, Ichikawa D, Kubota T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Sakakura C, Otsuji E. Poor prognostic subgroup in T3N0 stage IIA gastric cancer, suggesting an indication for adjuvant chemotherapy. J Surg Oncol 2015;111:221-5. [PMID: 25327711 DOI: 10.1002/jso.23796] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
11 Mehmedagic I, Hasukic S, Agic M, Kadric N, Hasukic I. Influence of Prognostic Factors for Recurrence of Adenocarcinoma of the Stomach. Med Arch 2016;70:441-4. [PMID: 28210017 DOI: 10.5455/medarh.2016.70.441-444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Liersch R, Biermann C, Mesters RM, Berdel WE. Lymphangiogenesis in cancer: current perspectives. Recent Results Cancer Res 2010;180:115-35. [PMID: 20033381 DOI: 10.1007/978-3-540-78281-0_8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
13 Kunisaki C, Makino H, Takagawa R, Oshima T, Nagano Y, Kosaka T, Ono HA, Otsuka Y, Akiyama H, Ichikawa Y. Tumor diameter as a prognostic factor in patients with gastric cancer. Ann Surg Oncol. 2008;15:1959-1967. [PMID: 18369676 DOI: 10.1245/s10434-008-9884-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
14 Yang Y, Du L, Yang X, Qu A, Zhang X, Zhou C, Wang C. Aberrant CCR4 expression is involved in tumor invasion of lymph node-negative human gastric cancer. PLoS One 2015;10:e0120059. [PMID: 25790118 DOI: 10.1371/journal.pone.0120059] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
15 Zhou Y, Cui JG, Huang F, Zhang A, Li C, Zhao ZC, Li WD, Fu WH. Prognostic Factors for Survival in Node-Negative Gastric Cancer Patients Who Underwent Curative Resection. Scand J Surg 2017;106:235-40. [PMID: 28376652 DOI: 10.1177/1457496916677878] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
16 Seshadri RA, Jayanand SB, Ranganathan R. Prognostic factors in patients with node-negative gastric cancer: an Indian experience. World J Surg Oncol 2011;9:48. [PMID: 21554745 DOI: 10.1186/1477-7819-9-48] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhou Y, Yu F, Wu L, Ye F, Zhang L, Li Y. Survival after Gastrectomy in Node-Negative Gastric Cancer: A Review and Meta-Analysis of Prognostic Factors. Med Sci Monit 2015;21:1911-9. [PMID: 26134762 DOI: 10.12659/MSM.893856] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Feng R, Sah BK, Li J, Lu S, Yuan F, Jin X, Yan M, Liu B, Li C, Zhu Z. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer. Cancer Biomark 2018;23:437-45. [PMID: 30248047 DOI: 10.3233/CBM-181526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Dittmar Y, Schüle S, Koch A, Rauchfuss F, Scheuerlein H, Settmacher U. Predictive factors for survival and recurrence rate in patients with node-negative gastric cancer—a European single-centre experience. Langenbecks Arch Surg 2015;400:27-35. [DOI: 10.1007/s00423-014-1226-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]